Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck (Q35659613)
Jump to navigation
Jump to search
scientific article published on 19 May 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck |
scientific article published on 19 May 2011 |
Statements
1 reference
Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck (English)
1 reference
Mohan Suntharalingam
1 reference
Young Kwok
1 reference
Olga Goloubeva
1 reference
Arti Parekh
1 reference
Rodney Taylor
1 reference
Jeffrey Wolf
1 reference
Ann Zimrin
1 reference
Scott Strome
1 reference
Robert Ord
1 reference
Kevin J Cullen
1 reference
19 May 2011
1 reference
82
1 reference
5
1 reference
1845-1850
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference